Home/Filings/4/0001209191-22-024535
4//SEC Filing

Hansard Adam 4

Accession 0001209191-22-024535

CIK 0001697532other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 7:07 PM ET

Size

5.6 KB

Accession

0001209191-22-024535

Insider Transaction Report

Form 4
Period: 2022-04-13
Hansard Adam
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-04-13+50,00050,000 total
    Exercise: $2.02Exp: 2032-04-13Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

Issuer

Applied Therapeutics Inc.

CIK 0001697532

Entity typeother

Related Parties

1
  • filerCIK 0001805556

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:07 PM ET
Size
5.6 KB